[Is activated protein C useful in low mortality risk?].
Bauer
C
C
Klinik für Anaesthesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum des Saarlandes, 66421 Homburg/Saar. aicbau@uniklinik-saarland.de
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012306:Risk; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality
D000933:Antifibrinolytic Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated